Video: New State Legislation Increases Oversight of Health Care Transactions – Thought Leaders in Health Law

From our Thought Leaders in Health Law video series: In today's complex and rapidly evolving health care landscape, navigating the path of expanding or selling a business requires a nuanced understanding of the intricate state and federal regulatory frameworks.

With states increasingly imposing legislative oversight to safeguard competition, care access, and quality, it's crucial for health care providers, private equity firms, and management organizations to have a strategic partner adept at handling these challenges.

States are imposing prior approval or prior review legislation to allow for more visibility regarding proposed transactions. Much of the legislation seeks to increase oversight of health care entity relationships with management companies and private equity firms.

What does this mean for you?

• New legislation that requires advance notice or pre-approval of health care transactions, creates new corporate practice of medicine prohibitions, or compels corporate transparency is affecting the ability of private equity firms and management companies to operate and work with patient-facing health care organizations.
• There are many issues to consider when expanding into a new market, investing in a health care venture, or buying or selling a health care business. Some of those issues include health care transaction restrictions, managed practice considerations, and state noncompete laws impacting health care entities.

Epstein Becker Green advises health care clients on the state and federal laws, as well as new and proposed legislation, that impact their expansion, investment, or divestiture initiatives or the relationships among health care organizations, investors, and management companies.

For more information on legislation affecting health care deals, visit State Legislation Impacting Health Care Transactions.